NIH-funded research NIH-funded research

Understanding Fibrin and Immune Cells in Gum Disease

Official title: Fibrin-neutrophil interaction in periodontitis immunopathology

Funded at Harvard Medical School · NIH-11160605 · Data updated 2026-11-12

This research explores how a protein called fibrin and immune cells called neutrophils work together in gum disease, especially in severe forms.

More Periodontitis research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionHarvard Medical School
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2026
Funding year2025
Award (this year)$236,256
NIH project number5R00DE030124-04
Project IDNIH-11160605 on NIH RePORTER

Who could benefit from this research

Could help

This research is particularly relevant for patients, especially adolescents, who experience severe forms of gum disease like ligneous periodontitis or aggressive common periodontitis.

Less likely to help

Patients with mild gum inflammation or those whose gum disease is not related to fibrin deposition may not directly benefit from this specific line of research.

What this research studies

Our mouths have immune responses that keep tissues healthy, but sometimes these responses go wrong and cause diseases like periodontitis, a severe gum disease. We are looking closely at a rare genetic condition called Plasminogen (Plg) deficiency, which causes a severe form of gum disease called ligneous periodontitis. In this condition, too much fibrin, a protein involved in clotting, builds up in the gums, leading to severe tissue and bone damage. We believe that understanding how fibrin interacts with immune cells like neutrophils in this severe form can help us understand and treat more common types of periodontitis. This work aims to uncover the exact ways these interactions lead to gum inflammation and bone loss.

Why it matters

Potential benefit: If successful, this work could lead to new ways to prevent or treat severe gum disease by targeting the interactions between fibrin and immune cells.

How similar studies have gone: While the general concept of immune responses in oral health is known, the specific mechanistic link between fibrin deposition and immunopathology in periodontitis is not yet fully understood, making this a novel area of focus supported by preliminary data.

Where this research is happening

  • Harvard Medical School
    Boston, United States
    Active

Researchers

  • Principal investigator: Silva, Munasinghage Lakmali — Harvard Medical School
  • Study coordinator: Silva, Munasinghage Lakmali

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.